Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,432.29
(
-0.92%
)
US TECH 100
28,489.02
(
-1.05%
)
Dow Jones
49,564.93
(
-1.00%
)
Brent Oil
106.70
(
2.42%
)
Bitcoin
79,283.67
(
-2.19%
)
News Focus
News Focus
Post# of 826222
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Hspooner

Send PM Follow Ignore
Followers 38
Posts 1156
Boards Moderated 0
Alias Born 03/20/2013

Hspooner

Re: flipper44 post# 719989

Saturday, 09/14/2024 9:20:26 AM

Saturday, September 14, 2024 9:20:26 AM

Post# of 826222
Flipper, it is all about PDL-1 expression by the cancers, MRK was more selective with their patient selection and thus limited the breadth of their indications. BMS went for all patients regardless of how much PDL-1 their tumors expressed and that diluted the efficacy measures.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News